找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Regulation of Cancer Immune Checkpoints; Molecular and Cellul Jie Xu Book 2020 The Editor(s) (if applicable) and The Author(s), under exclu

[復制鏈接]
查看: 31074|回復: 65
樓主
發(fā)表于 2025-3-21 19:38:15 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Regulation of Cancer Immune Checkpoints
副標題Molecular and Cellul
編輯Jie Xu
視頻videohttp://file.papertrans.cn/826/825656/825656.mp4
概述Systematically reviewing the most important findings in regulation of cancer immune checkpoints.Discussing the therapeutic development based on molecular and cellular mechanisms.Helping researchers bu
叢書名稱Advances in Experimental Medicine and Biology
圖書封面Titlebook: Regulation of Cancer Immune Checkpoints; Molecular and Cellul Jie Xu Book 2020 The Editor(s) (if applicable) and The Author(s), under exclu
描述.This book systematically reviews the most important findings on cancer immune checkpoints, sharing essential insights into this rapidly evolving yet largely unexplored research topic. The past decade has seen major advances in cancer immune checkpoint therapy, which has demonstrated impressive clinical benefits. The family of checkpoints for mediating cancer immune evasion now includes CTLA-4, PD-1/PD-L1, CD27/CD70, FGL-1/LAG-3, Siglec-15, VISTA (PD-1L)/VSIG3, CD47/SIRPA, APOE/LILRB4, TIGIT, and many others. Despite these strides, most patients do not show lasting remission, and some cancers have been completely resistant to the therapy. The potentially lethal adverse effects of checkpoint blockade represent another major challenge, the mechanisms of which remain poorly understood. Compared to the cancer signaling pathways, such as p53 and Ras, mechanistic studies on immune checkpoint pathways are still in their infancy. ..To improve the responses to checkpoint blockade therapy and limit the adverse effects, it is essential to understand the molecular regulation of checkpoint molecules in both malignant and healthy cells/tissues. This book begins with an introduction to immune che
出版日期Book 2020
關鍵詞Cancer; Immune checkpoints; Genetic regulation; Transcriptional regulation; Translational regulation; Pos
版次1
doihttps://doi.org/10.1007/978-981-15-3266-5
isbn_softcover978-981-15-3268-9
isbn_ebook978-981-15-3266-5Series ISSN 0065-2598 Series E-ISSN 2214-8019
issn_series 0065-2598
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor
The information of publication is updating

書目名稱Regulation of Cancer Immune Checkpoints影響因子(影響力)




書目名稱Regulation of Cancer Immune Checkpoints影響因子(影響力)學科排名




書目名稱Regulation of Cancer Immune Checkpoints網(wǎng)絡公開度




書目名稱Regulation of Cancer Immune Checkpoints網(wǎng)絡公開度學科排名




書目名稱Regulation of Cancer Immune Checkpoints被引頻次




書目名稱Regulation of Cancer Immune Checkpoints被引頻次學科排名




書目名稱Regulation of Cancer Immune Checkpoints年度引用




書目名稱Regulation of Cancer Immune Checkpoints年度引用學科排名




書目名稱Regulation of Cancer Immune Checkpoints讀者反饋




書目名稱Regulation of Cancer Immune Checkpoints讀者反饋學科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 23:32:56 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:01:11 | 只看該作者
地板
發(fā)表于 2025-3-22 07:44:06 | 只看該作者
Chushu Li,Bingqing Xia,Sheng Wang,Jie Xuprovision in host countries. It is of interest to all those who provide health services, create policy, and initiate legislation for these populations..978-1-4419-3556-4978-0-387-22693-4Series ISSN 1571-5507 Series E-ISSN 2197-7984
5#
發(fā)表于 2025-3-22 11:59:06 | 只看該作者
6#
發(fā)表于 2025-3-22 14:41:24 | 只看該作者
7#
發(fā)表于 2025-3-22 18:28:55 | 只看該作者
Yiting Wang,Ping Wang,Jie Xuprovision in host countries. It is of interest to all those who provide health services, create policy, and initiate legislation for these populations..978-1-4419-3556-4978-0-387-22693-4Series ISSN 1571-5507 Series E-ISSN 2197-7984
8#
發(fā)表于 2025-3-22 21:39:30 | 只看該作者
9#
發(fā)表于 2025-3-23 03:07:40 | 只看該作者
Haojie Lu,Caiyun Fangprovision in host countries. It is of interest to all those who provide health services, create policy, and initiate legislation for these populations..978-1-4419-3556-4978-0-387-22693-4Series ISSN 1571-5507 Series E-ISSN 2197-7984
10#
發(fā)表于 2025-3-23 06:32:39 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-31 22:15
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
美姑县| 淳化县| 九龙城区| 左权县| 梁平县| 太谷县| 滨州市| 丹巴县| 湟源县| 鄂温| 湾仔区| 隆德县| 堆龙德庆县| 清水县| 宣汉县| 兴宁市| 浦城县| 休宁县| 泽州县| 呈贡县| 平阴县| 民和| 汶川县| 霞浦县| 鄂托克旗| 萨嘎县| 伊金霍洛旗| 泌阳县| 万全县| 蕲春县| 浪卡子县| 黔东| 晋江市| 洪雅县| 房山区| 阿尔山市| 清丰县| 深圳市| 石阡县| 麦盖提县| 依兰县|